Objective Measurements of Lens Opacification After Intravitreal Injections (MOC-IVT)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03964597|
Recruitment Status : Withdrawn (Study abandoned before any submission (foreseeable organizational difficulties))
First Posted : May 28, 2019
Last Update Posted : January 22, 2020
The main hypothesis is the opacification of the lens would be increase by the IVT.
The opacification of the lens can be objectived by :
- the objective scatter index (OSI) on the OQAS device
- the average lens density (ALD) on the IOLMaster device.
Eligible patients will be followed at least 12 months after in intravitreal injection and the opacification of their lens is regularly controlled with OSI and ALD.
The objective is to study the dynamics of lens opacification in IVT-treated eyes evaluated by OSI for at least 1 year.
|Condition or disease||Intervention/treatment|
|Lens Opacification Intravitreal Injections (IVT)||Diagnostic Test: Measurement of lens opacification|
|Study Type :||Observational|
|Actual Enrollment :||0 participants|
|Official Title:||Objective Measurements of Lens Opacification After Intravitreal Injections (MOC-IVT)|
|Actual Study Start Date :||September 1, 2019|
|Actual Primary Completion Date :||September 1, 2019|
|Actual Study Completion Date :||September 1, 2019|
- Diagnostic Test: Measurement of lens opacification
Measurement of OSI and ALD at inclusion and during post-IVT follow-up visits to M3, M6, and M12, +/- M18, +/- M24 and +/- M30.
- Value of the OSI (Objective Scatter Index) in one year of follow-up after IVT [ Time Frame: 12 months ]